TransMedics Group, Inc.TMDXNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank89
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
27.72
↑ 162% vs avg
Percentile
P89
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-44.64
Historical baseline
PeriodValueYoY Change
202527.72-13.9%
202432.22+109.2%
2023-348.92-497.7%
2022-58.38-310.5%
2021-14.22+34.4%
2020-21.67-113.0%
2019-10.17+53.6%
2018-21.94-30.7%
2017-16.79-18.0%
2016-14.22-